Market-Moving News for October 3rd
Market-Moving News for October 3rd
LEVI: -12% | Levi Strauss & Co shares are trading lower after the company reported worse-than-expected Q3 sales results and issued its FY24 adjusted EPS guidance with its midpoint below estimates. The company began a strategic review for its Dockers brand and is exploring a potential sale or other strategic transactions.
LEVI：-12% | Levis Strauss & Co的股票下跌，因爲公司報告了低於預期的Q3銷售成績，併發布了FY24調整後的每股收益指引，中間點低於預期。公司已開始就其Dockers品牌展開戰略審查，並正在探索潛在的出售或其他戰略交易。
TOVX: 61% | Theriva Biologics Announces Outcome Of Data And Safety Monitoring Committee Review In Phase 1b/2a Clinical Trial Of SYN-004 In Allogeneic Hematopoietic Cell Transplant Recipients; The DSMC Has Recommended That The Study Proceed To Enroll Cohort 3
TOVX：61% | Theriva 生物製品宣佈阿洛基因造血幹細胞移植受試者中SYN-004的1b/2a臨床試驗數據和安全監測委員會審查結果; DSMC建議研究繼續招募第3隊。
NVDA: 2% | Nvidia CEO Jensen Huang Says Demand For Next-Gen Blackwell GPU Platform Insane: 'Everyone Wants To Have The Most, And Everyone Wants To Be First'
NVDA：2% | 英偉達CEO黃仁勳表示，對下一代Blackwell gpu芯片-雲計算平台的需求瘋狂：'每個人都想擁有最多，每個人都想第一'
譯文內容由第三人軟體翻譯。